Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study.
American Heart Journal.
Times cited: 19
Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension.
Journal of the American College of Cardiology.
Times cited: 157